1,267 posters, 47 videos, 13 topics, 4 sessions, 853 authors

SOHO 2026 Annual Meeting

September 9 - 12, 2026 | George R. Brown Convention Center, Houston, Texas

Posters

Showing 1,267 results.

Thumbnail for Survival and Cardiovascular Outcomes Associated With GLP-1 Receptor Agonist Exposure in Patients With Multiple Myeloma and Metabolic Comorbidities: A Propensity-Matched TriNetX Analysis

MM - 857

Survival and Cardiovascular Outcomes Associated With GLP-1 Receptor Agonist Exposure in Patients With Multiple Myeloma and Metabolic Comorbidities: A Propensity-Matched TriNetX Analysis

Nnamdi Omenuko

Poster Presenter: Nnamdi Omenuko

Thumbnail for Comparative Toxicity of Menin Inhibitor-Based Combination therapy in newly diagnosed Acute Myeloid Leukemia: Venetoclax-containing Versus Non-Venetoclax regimens

AML - 858

Comparative Toxicity of Menin Inhibitor-Based Combination therapy in newly diagnosed Acute Myeloid Leukemia: Venetoclax-containing Versus Non-Venetoclax regimens

Vaishnavi Rao

Poster Presenter: Vaishnavi Rao

Thumbnail for Mortality and Bleeding Tradeoffs Associated With Oral Anticoagulation in BTK Inhibitor-Treated Chronic Lymphocytic Leukemia Patients With Atrial Fibrillation/Flutter: A Propensity-Matched TriNetX Analysis

CLL - 860

Mortality and Bleeding Tradeoffs Associated With Oral Anticoagulation in BTK Inhibitor-Treated Chronic Lymphocytic Leukemia Patients With Atrial Fibrillation/Flutter: A Propensity-Matched TriNetX Analysis

Alexander Mays

Poster Presenter: Alexander Mays

Thumbnail for Urinary Mast Cell Metabolites Versus Serum Tryptase for Monitoring Clinical Response to Cytoreductive Therapy in Indolent Systemic Mastocytosis

MPN - 861

Urinary Mast Cell Metabolites Versus Serum Tryptase for Monitoring Clinical Response to Cytoreductive Therapy in Indolent Systemic Mastocytosis

Cecilia Arana-Yi

Poster Presenter: Cecilia Arana-Yi

CLL - 864

Infections in Chronic Lymphocytic Leukemia: A National Inpatient Sample Analysis of Prevalence and Mortality

Rabia Iqbal

Poster Presenter: Rabia Iqbal

ABCL - 865

Post-CAR-T Relapse in DLBCL: Real-World Salvage Therapy Patterns and Outcomes at a Tertiary Academic Center

Jivtesh Singh

Poster Presenter: Jivtesh Singh

$Thumbnail for Three-Year Follow-Up of Dose-Dense Mini-CVD in Combination with Inotuzumab Ozogamicin and Blinatumomab for Patients with Relapsed/Refractory B-cell Acute Lymphoblastic Leukemia$

ALL - 866

Three-Year Follow-Up of Dose-Dense Mini-CVD in Combination with Inotuzumab Ozogamicin and Blinatumomab for Patients with Relapsed/Refractory B-cell Acute Lymphoblastic Leukemia

Hannah Goulart

Poster Presenter: Hannah Goulart

Thumbnail for Postmarketing Safety Signals of Revumenib (Menin-KMT2A Inhibitor) vs Acute Myeloid Leukemia-Targeted Therapies: A Class-Restricted Disproportionality Analysis of the FDA Adverse Event Monitoring System (2016-2026)

AML - 867

Postmarketing Safety Signals of Revumenib (Menin-KMT2A Inhibitor) vs Acute Myeloid Leukemia-Targeted Therapies: A Class-Restricted Disproportionality Analysis of the FDA Adverse Event Monitoring System (2016-2026)

Arashdeep Singh

Poster Presenter: Arashdeep Singh

Thumbnail for Clinical Outcomes Among Anticoagulated Patients with CLL and Atrial Fibrillation/Flutter Treated with First- Versus Second-Generation BTK Inhibitors

CLL - 868

Clinical Outcomes Among Anticoagulated Patients with CLL and Atrial Fibrillation/Flutter Treated with First- Versus Second-Generation BTK Inhibitors

Nnamdi Omenuko

Poster Presenter: Nnamdi Omenuko